Biotecnología
Biotecnología
Johnson & Johnson Agrees to Acquire Proteologix
27/05/2024 -
Will integrate Proteologix’s bispecific antibodies into its pipeline.
NEOsphere, Kymera Therapeutics Collaborate on Novel Molecular Glue Target Discovery
16/05/2024 -
Aim to create opportunities to target previously undruggable disease-causing proteins.
Ingenza Secures Innovation Funding to Expand codABLE Gene Design Algorithm
06/05/2024 -
Will adapt its machine learning platform to precisely control recombinant protein expression in Pichia pastoris.
Abzena Introduces Enhanced Bioassay Platform
02/05/2024 -
EpiScreen 2.0 predicts and evaluates potential risks of preclinical immunogenicity in protein, antibody and gene therapy therapeutics.
Fujifilm & Predictive Oncology Tackle Protein Interference
02/05/2024 -
Enter a collaboration and co-marketing agreement to reduce protein interference in bacterial endotoxin testing of biopharmaceutical products.
Lonza Expands Spray-Drying Services for Protein-Based Inhaled Therapies
03/04/2024 -
New offering provides clinical and commercial manufacturing services at a kilogram scale from Lonza’s Bend (US) site.
Samsung Life Science Fund Invests in BrickBio
24/03/2024 -
Samsung affiliates will work with BrickBio to evaluate, manufacture, and develop therapies using BrickBio's protein engineering technology.
BostonGene Named Akoya Biosciences' Qualified CRO
24/03/2024 -
Will offer end-to-end spatial biology solutions to life sciences researchers for advanced spatial proteomics analysis.
ProteoNic Biosciences Partners with Ginkgo Bioworks to Support Clients
15/03/2024 -
Grants Ginkgo Bioworks’ customers access to ProteoNic's vector technology.
Key Proteo to Build New CLIA-Certified Lab
11/03/2024 -
Aims to expand its scope of operations to serve unaddressed newborn screening needs.
Polyplus Receives GMP Certification for Recombinant Protein & DNA Production
07/03/2024 -
Also adds an additional GMP clean room for the production of GMP cell banks.
Evaluating New Approaches to Developing AIDS Vaccines by Creating Virus-like Particles that Display HIV Antigens or by Using Live, Attenuated (Weakened), non-HIV Viruses to Express HIV Proteins
07/03/2024 -
A description of Ira Berkower's research program and related publications.
New Ways to Predict How Well Vaccines Protect Against Tuberculosis, Tularemia and Other Bacteria That Live Inside Cells
07/03/2024 -
A description of Karen Elkins's research program and related publications.
VantAI, BMS Partner to Accelerate Molecular Glue Drug Discovery
22/02/2024 -
Will leverage VantAI's geometric deep learning capabilities with Bristol Myers Squibb’s expertise in targeted protein degradation.
Firefly Bio Debuts with $94M Series A Funding Round
22/02/2024 -
Funding will support its novel platform for treating cancer by merging antibody-drug conjugates with protein degraders.
Biognosys Opens New Proteomics Facility in MA
01/02/2024 -
Expansion facilitates access to select proteomics contract research organization (CRO) services for the company’s US biopharma customers.
Entos Pharma Launches GMP Clinical Mfg. Facility in Carlsbad
30/01/2024 -
Will manufacture genetic medicines based on Entos Fusogenix PLV platform, including recombinant protein, mRNA, and plasmid DNA.
AGC Biologics to Open New Manufacturing Site in Japan
19/01/2024 -
Will offer preclinical through commercial services for mammalian-based protein biologics, cell therapies, and messenger RNA.
Abzena Launches AbZelect Platforms for Cell Line Development
19/01/2024 -
Designed to enable the rapid generation and selection of high-yielding mammalian CHO cell lines for therapeutic protein and recombinant vaccine production.
Eurofins Alphora Completes Pilot Scale mAbs Development Facility
19/01/2024 -
3,300 sq.-ft. facility dedicated to development and scaling of mAbs and other mammalian-based therapeutic proteins.
Healis, CKD Bio Ink Supply Deal to Develop Neuromodulator Protein
03/01/2024 -
Aims to develop CKDB-501 for major depressive disorder and post-traumatic stress disorder.
